Pyridoxine Hydrochloride | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Pyridoxine Hydrochloride
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Pyridoxine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

41 API Suppliers, 7 USDMF, 5 CEP/COS, 5 JDMF, 3 KDMF, 8 NDC API, 20 Listed Suppliers, $ API Reference Price

41 API Suppliers
7 USDMF
5 CEP/COS
5 JDMF
3 KDMF
8 NDC API
20 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

25 Drugs in Development

25 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

325 FDF Dossiers, 35 FDA Orange Book, 41 Europe, 8 Canada, 114 South Africa, 127 Listed Dossiers

325 FDF Dossiers
35 FDA Orange Book
41 Europe
8 Canada
114 South Africa
127 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML, INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL, INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL
SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML
SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML
INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL
INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 12 Evonik, 10 Rochem International Inc, 23 SPI Pharma, 23 DKSH, 2 Pharm-RX Chemical, 8 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 2 Kewpie Corporation, 17 Nanjing Well Pharmaceutical, 3 Pfanstiehl, 20 Kirsch Pharma, 4 ACG Worldwide, 15 Actylis, 3 Aeon Procare, 2 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 1 Avesta Pharma, 39 BASF, 1 Bioplus Life Sciences, 4 CD Formulation, 2 Clariant, 17 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 3 Finar, 15 Gangwal Chemicals, 9 Ideal Cures, 4 Ingredion Pharma Solutions, 22 Kerry, 3 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 23 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 12 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 39 Roquette, 18 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 4 Silverline Chemicals, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

101 Fillers, Diluents & Binders, 76 Coating Systems & Additives, 59 Thickeners and Stabilizers, 56 Solubilizers, 56 Parenteral, 51 Taste Masking, 44 Controlled & Modified Release, 43 Direct Compression, 41 Topical, 37 Disintegrants & Superdisintegrants, 35 Granulation, 34 Film Formers & Plasticizers, 24 Chewable & Orodispersible Aids, 24 Lubricants & Glidants, 23 Emulsifying Agents, 19 Rheology Modifiers, 15 Co-Processed Excipients, 12 Surfactant & Foaming Agents, 10 API Stability Enhancers, 9 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

101 Fillers, Diluents & Binders
76 Coating Systems & Additives
59 Thickeners and Stabilizers
56 Solubilizers
56 Parenteral
51 Taste Masking
44 Controlled & Modified Release
43 Direct Compression
41 Topical
37 Disintegrants & Superdisintegrants
35 Granulation
34 Film Formers & Plasticizers
24 Chewable & Orodispersible Aids
24 Lubricants & Glidants
23 Emulsifying Agents
19 Rheology Modifiers
15 Co-Processed Excipients
12 Surfactant & Foaming Agents
10 API Stability Enhancers
9 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 33 News #PharmaBuzz

1 Data Compilation #PharmaFlow
33 News #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 27 Regulatory FDF Prices

6 US Medicaid Prescriptions
27 Regulatory FDF Prices

MARKET PLACE

83 APIs, 8 FDF Dossiers, 1 EXCIPIENTS

83 APIs
8 FDF Dossiers
1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

4 US Patents, 2 Health Canada Patents

4 US Patents
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 JP, 19 Others

2 EDQM
2 JP
19 Others

ANALYTICAL

1 Analytical Methods

1 Analytical Methods

$ API Ref.Price (USD/KG) : 23 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2Duchesnay Inc.

filter Patent Reset all filters

2 All

01 12350195

02 12432945

filter Product Reset all filters

2 All

01 2Doxylamine Succinate | Pyridoxine Hydrochloride

filter Dosage Reset all filters

2 All

01 2Delayed Release Tablet

filter Exp Date Reset all filters

2 All

01 12021-06-21

02 12023-07-10

Product Main Page

01

Duchesnay Inc.

Doxylamine Succinate, Pyridoxine Hydrochloride

Peptide Process CMC

Not Confirmed

Duchesnay Inc.

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-07-10

Date Granted : 2004-11-23

Doxylamine Succinate, Pyridoxine Hydrochloride

Brand Name : DICLECTIN

Patent Number : 2432945

Filing Date : 2003-07-10

Strength per Unit : 10mg / 10mg per tablet

Dosage Form : Delayed Release Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-07-10

Date Granted : 2004-11-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Duchesnay Inc.

Doxylamine Succinate, Pyridoxine Hydrochloride

Peptide Process CMC

Not Confirmed

Duchesnay Inc.

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-06-21

Date Granted : 2003-06-10

Doxylamine Succinate, Pyridoxine Hydrochloride

Brand Name : DICLECTIN

Patent Number : 2350195

Filing Date : 2001-06-21

Strength per Unit : 10mg / 10mg per tablet

Dosage Form : Delayed Release Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-06-21

Date Granted : 2003-06-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!